The MycoTOX Profile provides a comprehensive assessment of mycotoxin exposure by screening for 11 different mycotoxins produced by over 40 species of mould. Using advanced mass spectrometry (MS/MS), the test measures a wide range of fungal toxins including ochratoxin A, aflatoxin M1, sterigmatocystin, zearalenone, gliotoxin, roridin E, verrucarin A, enniatin B1, mycophenolic acid, dihydrocitrinone and chaetoglobosin A. This broad coverage offers a detailed overview of mould-related toxic load from a single urine sample.
The test may be clinically useful when investigating symptoms that could be associated with environmental or food-based mould exposure. By assessing metabolites linked with major mould genera such as Aspergillus, Penicillium, Fusarium and Stachybotrys, the profile can help identify patterns of exposure relevant to fatigue, respiratory irritation, skin reactions, neurological symptoms or digestive disturbance. The molecular specificity of MS/MS detection also allows for evaluation of low-level exposures.
The MycoTOX Profile offers a structured way to assess mycotoxin burden and can be used to support clinical interpretation when evaluating unexplained symptom patterns. Its broad toxin panel provides practitioners with detailed biochemical information to help inform next steps, guide environmental assessment or complement broader metabolic or detoxification testing strategies.
